Jump to content

Avecia

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by InternetArchiveBot (talk | contribs) at 11:02, 22 October 2016 (Rescuing 5 sources and tagging 0 as dead. #IABot (v1.2.5)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Avecia- a part of Nitto Denko Inc.[1]- is a leading private biotechnology company focused on the development and manufacture of innovative biotechnology-based medicines. Avecia operates as a contract manufacturing organization (CMO), specializing in oligonucleotide production.

Avecia has two US FDA-audited facilities, one near Boston, MA, and the second in Cincinnati, OH. The combined capacity of these two sites allows Avecia to handle oligonucleotide programs from the pre-clinical through commercial stages.

References

  1. ^ http://www.nitto.com www.nitto.com